Clinical Trials Using Anti-FCRH5/CD3 BiTE Antibody BFCR4350A
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-FCRH5/CD3 BiTE Antibody BFCR4350A. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R / R MM)
This is a phase I, multicenter, open-label, dose-escalation study of BFCR4350A administered as a single agent by IV infusion to participants with relapsed or refractory multiple myeloma (R / R MM).
Location: 6 locations